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Conclusions: The introduction of MRI based BT in our clinic 
was feasible and the treatment results were similar to other 
published series. The rate of significant side effects 
encourages us to elaborate the plan modification techniques, 
apply interstitial needles and treat all pts with individual 
plan in the future. 
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Purpose/Objective: Contouring the bowel is one of the most 
time consuming aspects of planning a HDR treatment of the 
cervix. This investigates the possibility of reducing the 
volume of bowel to be contoured for planning purposes when 
treating the Cervix with HDR using a Tandem and Ovoid 
Applicator with CT simulation. It is hoped that the service 
efficiency can be improved by reducing the volume of bowel 
contoured prior to planning. 
Materials and Methods: Additional contours were 
constructed on previous patient plans which were clinically 
accepted. Using Oncentra Brachy (Version 4.3), 3D margins of 
0.5cm, 1.0cm, 1.5cm and 2.0cm were grown around the HR-
CTV. The overlap of the original (complete) bowel volume 
and the newly created volumes was extracted to produce a 
bowel contour which was limited to within a given distance 
from the HR-CTV. For example, taking the intersection of the 
‘Bowel’ and the ‘HRCTV + 1.0cm’ to give a bowel contour 
which only extends to 1.0cm beyond the HR-CTV (referred to 
as ‘HR-CTV + 1.0cm & Bowel’) This produced a set of bowel 
outlines which were limited to within a given margin of the 
HR-CTV. The dosimetric parameters (D2cc, D1cc, D0.1cc) 
reported by Oncentra were recorded for the original bowel 
volume, as well as the limited bowel volumes produced to 
enable comparison. 
Results: A total of 10 plans were contoured and assessed, 
with comparison of the dosimetric parameters performed for 
the limited bowel volumes. A summary of the results is given 
in the table. The mean doses for the fully contoured bowel 
were 3.99Gy, 4.39Gy and 5.37Gy for the D2cc, D1cc and 
D0.1cc respectively . When the bowel was limited to within 
1.5cm or less of the HR-CTV there was at least one contour 
which did not give sufficient volume to produce complete 
dose statistics. When considering contouring within a 2.0cm 
margin of the HR-CTV the mean change in the D0.1cc was 
less than 0.1Gy (with D2cc and D1cc being less than 0.05Gy). 
The reduction in volume contoured however was large, with a 
reduction of around 65% in volume when restricting 
contouring to within 2.0cm of the HR-CTV. 
 
 
Conclusions: Restricting the bowel contouring for planning of 
treatments of the Cervix using Tandem and Ovoid applicators 
with CT simulation to within 2.0cm of the HR-CTV has the 
potential to reduce the volume contoured by 65%. This 
results in a change in reported dose statistics of less than 
0.1Gy for the D0.1cc and less than 0.05Gy for the D1cc and 
D2cc. These small changes would not have an effect on the 
clinical decision to treat using the produced plans. 
By producing a an expanded HR-CTV contour, the bowel 
contouring could be easily limited to within this region, thus 
reducing the time taken to contour, ultimately leading to a 
more efficient treatment delivery. Applying this to other 
organs at risk may also be possible. 
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Purpose/Objective: Aim of this study was to evaluate vaginal 
recurrence rate and toxicity after postoperative vaginal 
brachytherapy (VBT) in patients (pts) with early stage 
endometrial cancer.  
